Top Growth Trends in the Cardiac Resynchronization Therapy Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Does the Projected Growth of the Cardiac Resynchronization Therapy Market Compare Over the Forecast Period?
The market size of cardiac resynchronization therapy has experienced robust growth in the past few years. It is projected to escalate from $6.29 billion in 2024 to $6.74 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this growth during the historic period include the augmenting elderly population, a surge in heart failure cases, rising investment in R&D for the innovation of CRT devices, increased recognition of the advantages conferred by this therapy, physician education programs, and the evolving competitive landscape in this sector.
In the upcoming years, the cardiac resynchronization therapy market is projected to witness robust growth, reaching $8.77 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. This growth during the forecasted period is primarily driven by the growing incidence of heart failure and cardiac diseases, an aging population, a rising number of cardiovascular ailments, the demand for CRT therapy, advancements in pacemaker and defibrillator treatments, and increased awareness regarding CRT therapy. The key trends for the forecast period comprise the preference for CRT-D devices over conventional pacemakers, the adoption of cutting-edge technology, the expansion of CRT therapy, incorporation of artificial intelligence, and the use of machine learning.
What Key Drivers Are Accelerating the Growth of the Cardiac Resynchronization Therapy Market During the Forecast Period?
The surge in cardiovascular disease cases is anticipated to steer the cardiac resynchronization therapy market towards growth. Illnesses that impact the heart and blood vessels are categorized under Cardiovascular diseases (CVD). The proliferation of CVD is attributed to various factors such as growing older population, unhealthy living habits, escalating tobacco consumption, a lack of physical activity, and poor dietary practices. Cardiac resynchronization therapy (CRT) aids in managing cardiovascular diseases like heart failure by enhancing the synchronization of cardiac contractions through the provision of coordinated electrical stimuli. For instance, the Minnesota Department of Health reported in September 2024 that about 30% of Minnesota’s adult population experienced high blood pressure in 2023, which was around 1.4 million people. Additionally, hypertensive diseases caused or contributed to the demise of 14,225 residents in 2022, accounting for nearly 28% of the state’s total deaths. Accordingly, the rising incidence of cardiovascular diseases is fuelling the expansion of the cardiac resynchronization therapy market. Rising healthcare expenditures are further expected to stimulate the growth of the cardiac resynchronization therapy market. Investment in healthcare is critical to advance research and development in cardiac resynchronization therapy, leading to technological innovations, better accessibility to treatment, and a broader approach to individual health and healthcare systems. For instance, in May 2023, the UK’s Office for National Statistics reported a nominal increase of 9.4% and real increase of 9.7% in healthcare spending. In 2021, the UK’s healthcare cost amounted to $367.25 billion (£280.7 billion), pharmaceutical expenses were $51.84 billion (£39.6 billion), and preventative care spending significantly rose to $45.93 billion (£35.1 billion). Furthermore, in September 2024, Cross River Therapy reported that the U.S. pharmaceutical sector generated $550 billion revenue, with $576.9 billion spent on medicines in 2021 in the U.S. This figure is estimated to rise to between $605-$635 billion by 2025. Consequently, escalating healthcare expenditure is propelling the growth of the cardiac resynchronization therapy market.
Get Your Free Sample of the Global Cardiac Resynchronization Therapy Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15531&type=smp
Who Are the Key Players Steering the Development of the Cardiac Resynchronization Therapy Market?
Major companies operating in the cardiac resynchronization therapy market are:
• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Terumo Corporation
• Biotronik SE & Co. KG
How Are Consumer Trends Shaping the Current and Future Landscape of the Cardiac Resynchronization Therapy Market?
Leading corporations in the cardiac resynchronization therapy (CRT) market are concentrating on the creation of implantable devices to enhance the results of heart failure treatment. CRT’s implantable devices facilitate the synchronous contraction of the heart’s ventricles, boosting pumping efficacy and controlling heart failure symptoms. For instance, MicroPort Scientific Corporation, a medical instrument company from China, introduced the GALI SonR cardiac resynchronization therapy and defibrillation device (CRT-D), along with the Navigo 4LV left-ventricular pacing leads in Japan, in February 2024. This is the first and sole CRT hemodynamic sensor designed to automatically adjust patients on a weekly basis and more importantly, during patient activity, permitting optimization in real-life conditions. A 35% reduction in heart failure hospitalization risk has been demonstrated by the clinically validated SonR algorithm, which will also contribute to the safety and well-being of the CRT-D patient.
Get Instant Access to the Global Cardiac Resynchronization Therapy Market Report with Swift Delivery!
How Are Key Segments Defining the Competitive Landscape of the Cardiac Resynchronization Therapy Market?
The cardiac resynchronization therapy market covered in this report is segmented –
1) By Type: Cardiac Resynchronization Therapy (CRT)-Defibrillator, Cardiac Resynchronization Therapy (CRT)-Pacemaker
2) By Age: Below 44 Years, 45-64 Years, 65-84 Years, Above 85 Years
3) By End-Use: Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers
Subsegments:
1) By Cardiac Resynchronization Therapy (CRT)-Defibrillator: Single-Chamber CRT-D, Dual-Chamber CRT-D, Triple-Chamber CRT-D, Bi-Ventricular CRT-D
2) By Cardiac Resynchronization Therapy (CRT)-Pacemaker: Single-Chamber CRT-P, Dual-Chamber CRT-P, Triple-Chamber CRT-P, Bi-Ventricular CRT-P
Which Geographical Regions Are Shaping the Cardiac Resynchronization Therapy Market Growth?
North America was the largest region in the cardiac resynchronization therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac resynchronization therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Cardiac Resynchronization Therapy Market?
Cardiac resynchronization therapy (CRT) is a treatment for heart failure that helps to coordinate the contractions of the heart’s ventricles. Cardiac resynchronization therapy uses a biventricular pacemaker to send electrical impulses to the heart muscle, allowing the ventricles to beat in a more synchronized manner. It can improve the symptoms of heart failure, such as shortness of breath and fatigue, and the heart’s overall function.
Browse Through More Similar Reports By The Business Research Company:
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Vitamin D Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
